Skip to main content
Journal ArticleOPEN ACCESS

Glutamine antagonists may KEAP lung cancer in check

Science Advances (2024) 10(13)
DOI: 10.1126/sciadv.ado7808
0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The glutamine antagonist DRP-104 blocks purine synthesis and combines with checkpoint inhibitors to promote antitumor immunity in KEAP1/NRF2-mutant lung cancers.

Cite

CITATION STYLE

APA

Blatt, E. B., & DeBerardinis, R. J. (2024). Glutamine antagonists may KEAP lung cancer in check. Science Advances, 10(13). https://doi.org/10.1126/sciadv.ado7808

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free